Annual Net Income
-$54.19 M
-$14.49 M-36.51%
31 December 2023
Summary:
Abeona Therapeutics annual net profit is currently -$54.19 million, with the most recent change of -$14.49 million (-36.51%) on 31 December 2023. During the last 3 years, it has risen by +$30.05 million (+35.67%). ABEO annual net income is now -1317.98% below its all-time high of $4.45 million, reached on 31 December 2013.ABEO Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$30.27 M
-$37.67 M-508.71%
30 September 2024
Summary:
Abeona Therapeutics quarterly net profit is currently -$30.27 million, with the most recent change of -$37.67 million (-508.71%) on 30 September 2024. Over the past year, it has dropped by -$18.43 million (-155.74%). ABEO quarterly net income is now -252.67% below its all-time high of $19.83 million, reached on 31 December 2012.ABEO Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$71.03 M
-$18.43 M-35.04%
30 September 2024
Summary:
Abeona Therapeutics TTM net profit is currently -$71.03 million, with the most recent change of -$18.43 million (-35.04%) on 30 September 2024. Over the past year, it has dropped by -$26.31 million (-58.84%). ABEO TTM net income is now -380.19% below its all-time high of $25.35 million, reached on 30 September 2013.ABEO TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABEO Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -36.5% | -155.7% | -58.8% |
| 3 y3 years | +35.7% | -329.7% | -31.3% |
| 5 y5 years | +4.4% | -74.2% | +8.1% |
ABEO Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -36.5% | +36.2% | -508.7% | +35.2% | -165.4% | +21.9% |
| 5 y | 5 years | -36.5% | +36.2% | -508.7% | +37.1% | -165.4% | +32.9% |
| alltime | all time | -1318.0% | +36.2% | -252.7% | +37.1% | -380.2% | +32.9% |
Abeona Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$30.27 M(-508.7%) | -$71.03 M(+35.0%) |
| June 2024 | - | $7.41 M(-123.5%) | -$52.60 M(-31.4%) |
| Mar 2024 | - | -$31.58 M(+90.3%) | -$76.66 M(+41.5%) |
| Dec 2023 | -$54.19 M(+36.5%) | -$16.59 M(+40.2%) | -$54.19 M(+21.2%) |
| Sept 2023 | - | -$11.84 M(-28.9%) | -$44.72 M(+13.7%) |
| June 2023 | - | -$16.65 M(+82.9%) | -$39.32 M(+46.9%) |
| Mar 2023 | - | -$9.11 M(+27.9%) | -$26.76 M(-32.6%) |
| Dec 2022 | -$39.70 M(-53.3%) | -$7.12 M(+10.7%) | -$39.70 M(-49.9%) |
| Sept 2022 | - | -$6.43 M(+57.0%) | -$79.26 M(-0.8%) |
| June 2022 | - | -$4.10 M(-81.4%) | -$79.87 M(-12.2%) |
| Mar 2022 | - | -$22.04 M(-52.8%) | -$90.98 M(+7.1%) |
| Dec 2021 | -$84.94 M(+0.8%) | -$46.68 M(+562.7%) | -$84.94 M(+57.1%) |
| Sept 2021 | - | -$7.04 M(-53.7%) | -$54.08 M(-0.4%) |
| June 2021 | - | -$15.21 M(-5.0%) | -$54.27 M(+4.2%) |
| Mar 2021 | - | -$16.00 M(+1.1%) | -$52.08 M(-38.2%) |
| Dec 2020 | -$84.23 M(+10.4%) | -$15.83 M(+118.7%) | -$84.23 M(-0.7%) |
| Sept 2020 | - | -$7.24 M(-44.4%) | -$84.84 M(-10.7%) |
| June 2020 | - | -$13.01 M(-73.0%) | -$94.97 M(-10.3%) |
| Mar 2020 | - | -$48.16 M(+193.1%) | -$105.89 M(+38.8%) |
| Dec 2019 | -$76.28 M(+34.6%) | -$16.43 M(-5.4%) | -$76.28 M(-1.4%) |
| Sept 2019 | - | -$17.37 M(-27.4%) | -$77.33 M(+1.2%) |
| June 2019 | - | -$23.92 M(+28.9%) | -$76.38 M(+18.1%) |
| Mar 2019 | - | -$18.55 M(+6.2%) | -$64.70 M(+14.2%) |
| Dec 2018 | -$56.67 M(+107.4%) | -$17.48 M(+6.5%) | -$56.67 M(+19.0%) |
| Sept 2018 | - | -$16.42 M(+34.1%) | -$47.64 M(+30.3%) |
| June 2018 | - | -$12.24 M(+16.3%) | -$36.57 M(+12.2%) |
| Mar 2018 | - | -$10.53 M(+24.6%) | -$32.60 M(+19.3%) |
| Dec 2017 | -$27.32 M(+24.9%) | -$8.45 M(+58.2%) | -$27.32 M(+5.6%) |
| Sept 2017 | - | -$5.34 M(-35.5%) | -$25.87 M(+11.7%) |
| June 2017 | - | -$8.28 M(+57.8%) | -$23.15 M(+7.3%) |
| Mar 2017 | - | -$5.25 M(-25.1%) | -$21.58 M(-1.4%) |
| Dec 2016 | -$21.87 M(+50.6%) | -$7.00 M(+166.8%) | -$21.87 M(+27.1%) |
| Sept 2016 | - | -$2.62 M(-60.9%) | -$17.21 M(-16.7%) |
| June 2016 | - | -$6.70 M(+20.9%) | -$20.66 M(+14.3%) |
| Mar 2016 | - | -$5.54 M(+136.9%) | -$18.07 M(+24.4%) |
| Dec 2015 | -$14.53 M(-45.8%) | -$2.34 M(-61.5%) | -$14.53 M(-39.8%) |
| Sept 2015 | - | -$6.07 M(+47.7%) | -$24.13 M(+23.6%) |
| June 2015 | - | -$4.11 M(+105.7%) | -$19.52 M(-30.1%) |
| Mar 2015 | - | -$2.00 M(-83.3%) | -$27.92 M(+4.3%) |
| Dec 2014 | -$26.78 M(-701.9%) | -$11.94 M(+713.0%) | -$26.78 M(+68.3%) |
| Sept 2014 | - | -$1.47 M(-88.3%) | -$15.91 M(+9.0%) |
| June 2014 | - | -$12.51 M(+1356.0%) | -$14.60 M(+2873.1%) |
| Mar 2014 | - | -$859.00 K(-20.1%) | -$491.00 K(-111.0%) |
| Dec 2013 | $4.45 M(-142.2%) | -$1.07 M(+584.7%) | $4.45 M(-82.5%) |
| Sept 2013 | - | -$157.00 K(-109.8%) | $25.35 M(+138.2%) |
| June 2013 | - | $1.60 M(-60.8%) | $10.64 M(-782.6%) |
| Mar 2013 | - | $4.08 M(-79.4%) | -$1.56 M(-85.2%) |
| Dec 2012 | -$10.53 M(+316.0%) | $19.83 M(-233.4%) | -$10.53 M(-65.0%) |
| Sept 2012 | - | -$14.87 M(+40.3%) | -$30.08 M(+102.4%) |
| June 2012 | - | -$10.60 M(+116.7%) | -$14.86 M(+169.0%) |
| Mar 2012 | - | -$4.89 M(-1840.9%) | -$5.53 M(+118.2%) |
| Dec 2011 | -$2.53 M | $281.00 K(-19.7%) | -$2.53 M(+396.5%) |
| Sept 2011 | - | $350.00 K(-127.7%) | -$510.00 K(-96.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2011 | - | -$1.26 M(-33.4%) | -$13.58 M(+29.0%) |
| Mar 2011 | - | -$1.90 M(-182.5%) | -$10.53 M(+39.6%) |
| Dec 2010 | -$7.54 M(-56.5%) | $2.30 M(-118.1%) | -$7.54 M(-59.9%) |
| Sept 2010 | - | -$12.72 M(-810.6%) | -$18.81 M(+85.1%) |
| June 2010 | - | $1.79 M(+64.4%) | -$10.16 M(-28.2%) |
| Mar 2010 | - | $1.09 M(-112.1%) | -$14.16 M(-18.3%) |
| Dec 2009 | -$17.34 M(-44.8%) | -$8.97 M(+120.4%) | -$17.34 M(+65.7%) |
| Sept 2009 | - | -$4.07 M(+84.4%) | -$10.46 M(+0.5%) |
| June 2009 | - | -$2.21 M(+5.7%) | -$10.41 M(-0.3%) |
| Mar 2009 | - | -$2.09 M(-0.3%) | -$10.45 M(-44.9%) |
| Dec 2008 | -$31.43 M(+44.6%) | -$2.10 M(-47.9%) | -$18.95 M(-37.7%) |
| Sept 2008 | - | -$4.02 M(+79.3%) | -$30.41 M(+7.3%) |
| June 2008 | - | -$2.24 M(-78.8%) | -$28.35 M(+0.5%) |
| Mar 2008 | - | -$10.60 M(-21.8%) | -$28.21 M(+29.7%) |
| Dec 2007 | -$21.74 M(+68.9%) | -$13.55 M(+592.4%) | -$21.74 M(+100.1%) |
| Sept 2007 | - | -$1.96 M(-7.2%) | -$10.87 M(-0.5%) |
| June 2007 | - | -$2.11 M(-48.9%) | -$10.92 M(-10.1%) |
| Mar 2007 | - | -$4.13 M(+54.5%) | -$12.14 M(-5.7%) |
| Dec 2006 | -$12.87 M(+657.3%) | -$2.67 M(+32.6%) | -$12.87 M(+256.2%) |
| Sept 2006 | - | -$2.02 M(-39.5%) | -$3.61 M(-1.3%) |
| June 2006 | - | -$3.33 M(-31.4%) | -$3.66 M(-11.2%) |
| Mar 2006 | - | -$4.86 M(-173.7%) | -$4.13 M(+142.7%) |
| Dec 2005 | -$1.70 M(-83.4%) | $6.59 M(-419.2%) | -$1.70 M(-84.8%) |
| Sept 2005 | - | -$2.06 M(-45.6%) | -$11.19 M(-3.1%) |
| June 2005 | - | -$3.79 M(+56.1%) | -$11.56 M(+12.0%) |
| Mar 2005 | - | -$2.43 M(-16.4%) | -$10.32 M(+0.8%) |
| Dec 2004 | -$10.24 M(+47.6%) | -$2.91 M(+19.7%) | -$10.24 M(+2.7%) |
| Sept 2004 | - | -$2.43 M(-4.9%) | -$9.97 M(+2.3%) |
| June 2004 | - | -$2.55 M(+8.6%) | -$9.74 M(+41.7%) |
| Mar 2004 | - | -$2.35 M(-10.7%) | -$6.88 M(-0.9%) |
| Dec 2003 | -$6.93 M(-26.1%) | -$2.63 M(+19.4%) | -$6.93 M(+4.2%) |
| Sept 2003 | - | -$2.21 M(-798.1%) | -$6.65 M(-8.9%) |
| June 2003 | - | $316.00 K(-113.1%) | -$7.30 M(-26.4%) |
| Mar 2003 | - | -$2.41 M(+2.5%) | -$9.93 M(+5.8%) |
| Dec 2002 | -$9.38 M(+55.7%) | -$2.35 M(-17.7%) | -$9.38 M(+8.8%) |
| Sept 2002 | - | -$2.86 M(+23.8%) | -$8.63 M(+14.8%) |
| June 2002 | - | -$2.31 M(+23.7%) | -$7.51 M(+11.8%) |
| Mar 2002 | - | -$1.87 M(+17.0%) | -$6.72 M(+11.5%) |
| Dec 2001 | -$6.03 M(+11.0%) | -$1.59 M(-8.5%) | -$6.03 M(+0.0%) |
| Sept 2001 | - | -$1.74 M(+15.0%) | -$6.02 M(+7.8%) |
| June 2001 | - | -$1.52 M(+29.5%) | -$5.59 M(+1.3%) |
| Mar 2001 | - | -$1.17 M(-26.4%) | -$5.52 M(+1.7%) |
| Dec 2000 | -$5.43 M(+64.1%) | -$1.59 M(+21.5%) | -$5.43 M(+14.4%) |
| Sept 2000 | - | -$1.31 M(-9.4%) | -$4.74 M(+14.8%) |
| June 2000 | - | -$1.45 M(+33.9%) | -$4.13 M(+15.2%) |
| Mar 2000 | - | -$1.08 M(+18.9%) | -$3.59 M(+8.5%) |
| Dec 1999 | -$3.31 M(-2.7%) | -$908.00 K(+29.7%) | -$3.31 M(+37.8%) |
| Sept 1999 | - | -$700.00 K(-22.2%) | -$2.40 M(+41.2%) |
| June 1999 | - | -$900.00 K(+12.5%) | -$1.70 M(+112.5%) |
| Mar 1999 | - | -$800.00 K | -$800.00 K |
| Dec 1998 | -$3.40 M(-23.4%) | - | - |
| Dec 1997 | -$4.44 M(-61.3%) | - | - |
| Dec 1996 | -$11.46 M(-3461.3%) | - | - |
| Dec 1995 | $341.00 K | - | - |
FAQ
- What is Abeona Therapeutics annual net profit?
- What is the all time high annual net income for Abeona Therapeutics?
- What is Abeona Therapeutics annual net income year-on-year change?
- What is Abeona Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Abeona Therapeutics?
- What is Abeona Therapeutics quarterly net income year-on-year change?
- What is Abeona Therapeutics TTM net profit?
- What is the all time high TTM net income for Abeona Therapeutics?
- What is Abeona Therapeutics TTM net income year-on-year change?
What is Abeona Therapeutics annual net profit?
The current annual net income of ABEO is -$54.19 M
What is the all time high annual net income for Abeona Therapeutics?
Abeona Therapeutics all-time high annual net profit is $4.45 M
What is Abeona Therapeutics annual net income year-on-year change?
Over the past year, ABEO annual net profit has changed by -$14.49 M (-36.51%)
What is Abeona Therapeutics quarterly net profit?
The current quarterly net income of ABEO is -$30.27 M
What is the all time high quarterly net income for Abeona Therapeutics?
Abeona Therapeutics all-time high quarterly net profit is $19.83 M
What is Abeona Therapeutics quarterly net income year-on-year change?
Over the past year, ABEO quarterly net profit has changed by -$18.43 M (-155.74%)
What is Abeona Therapeutics TTM net profit?
The current TTM net income of ABEO is -$71.03 M
What is the all time high TTM net income for Abeona Therapeutics?
Abeona Therapeutics all-time high TTM net profit is $25.35 M
What is Abeona Therapeutics TTM net income year-on-year change?
Over the past year, ABEO TTM net profit has changed by -$26.31 M (-58.84%)